RWANDA and the International Vaccine Institute (IVI) signed an agreement Monday to establish the institute’s African Regional Office in Kigali, the Rwandan capital.
The agreement, signed by Rwanda’s Minister of Health Sabin Nsanzimana and IVI Director-General Jerome Kim, paves the way for the regional headquarters to serve as a hub for global health research, innovation, and collaboration, the Ministry of Health said in a statement late Monday night.
“The establishment of the International Vaccine Institute in Rwanda marks a significant step towards the sustained advancement of healthcare research and equitable access to vaccines across the continent and beyond,” said Nsanzimana, adding that Rwanda is committed to addressing vaccine inequities through local production of vaccines, therapeutics, and other life-saving medical products.
The Kigali-based IVI office said it will represent IVI in Africa, expand its member base and engagement, and emphasize clinical trial training capacity. It will also foster joint grant applications with local partners to accelerate vaccine research and innovation across the continent.
The IVI, headquartered in Seoul, the Republic of Korea, was established in 1997 under the initiative of the United Nations Development Programme.
— Xinhua
#Global New Light Of Myanmar